Raymond James & Associates Jazz Pharmaceuticals PLC Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Raymond James & Associates holds 53,611 shares of JAZZ stock, worth $5.98 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,611
Previous 47,318
13.3%
Holding current value
$5.98 Million
Previous $5.05 Million
18.32%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding JAZZ
# of Institutions
499Shares Held
57.3MCall Options Held
155KPut Options Held
152K-
Vanguard Group Inc Valley Forge, PA6.32MShares$705 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.15MShares$686 Million0.02% of portfolio
-
Lsv Asset Management Chicago, IL2.48MShares$277 Million0.58% of portfolio
-
Capital World Investors Los Angeles, CA2.02MShares$225 Million0.04% of portfolio
-
State Street Corp Boston, MA2.02MShares$225 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.99B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...